A Rosy Prognosis For Biotech | IBD Weekly, September 19, 2022

A Rosy Prognosis For Biotech | IBD Weekly, September 19, 2022

Regular price
$9.00 USD
Sale price
$9.00 USD
Regular price
$12.00 USD
Sold out
Unit price
per 
Shipping calculated at checkout.

OVERVIEW

Full newsprint issue IBD Weekly for the Week of September 19, 2022.

Cover Story: A Rosy Prognosis For Biotech - Stock after stock is bucking the bad market, and for good reason

Also:

  • The Lady Inventor
  • Merck Gamble Pays Off
  • A Diagnostics Champ
  • British Funds Struggle

Published by: Investor's Business Daily

Vol. 39 No. 24